Literature DB >> 18240337

Prenatal diagnosis of cystic fibrosis: the 18-year experience of Brittany (western France).

Virginie Scotet1, Ingrid Duguépéroux, Marie-Pierre Audrézet, Martine Blayau, Pierre Boisseau, Hubert Journel, Philippe Parent, Claude Férec.   

Abstract

OBJECTIVE: This study reports 18 years of experience in prenatal diagnosis (PD) of cystic fibrosis (CF) in a region where CF is frequent and the uptake of PD is common (Brittany, western France).
METHOD: All PDs made over the period 1989-2006 in women living in Brittany were collected.
RESULTS: We recorded 268 PDs made in 1 in 4 risk couples, plus 22 PDs directly made following the sonographic finding of echogenic bowel. Most of the 268 PDs were done in couples already having CF child(ren) (n = 195, 72.8%). Close to one-fifth followed cascade screening (n = 49, 18.3%), which identified 26 new 1 in 4 risk couples among the relatives of CF patients or of carriers identified through newborn screening (NBS). The remaining PDs were mainly made in couples whose 1 in 4 risk was evidenced following the diagnosis of echogenic bowel in a previous pregnancy (n = 22, 8.2%). Although patients' life expectancy has considerably improved, in our population the great majority of couples chose pregnancy termination when PD indicated that the foetus had CF (95.9%).
CONCLUSION: This study describes the distribution of PDs according to the context in which the 1 in 4 risk was discovered and highlights the real decisions of couples as regards pregnancy termination after a positive PD. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18240337     DOI: 10.1002/pd.1910

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2.

Authors:  Marianne Carlon; Jaan Toelen; Anke Van der Perren; Luk H Vandenberghe; Veerle Reumers; Lourenço Sbragia; Rik Gijsbers; Veerle Baekelandt; Uwe Himmelreich; James M Wilson; Jan Deprest; Zeger Debyser
Journal:  Mol Ther       Date:  2010-07-27       Impact factor: 11.454

2.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

3.  Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.

Authors:  Sharon J M Kessels; Drew Carter; Benjamin Ellery; Skye Newton; Tracy L Merlin
Journal:  Genet Med       Date:  2019-08-30       Impact factor: 8.822

4.  Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France.

Authors:  Virginie Scotet; Ingrid Duguépéroux; Philippe Saliou; Gilles Rault; Michel Roussey; Marie-Pierre Audrézet; Claude Férec
Journal:  Orphanet J Rare Dis       Date:  2012-03-01       Impact factor: 4.123

5.  Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples.

Authors:  Caroline E Ghiossi; James D Goldberg; Imran S Haque; Gabriel A Lazarin; Kenny K Wong
Journal:  J Genet Couns       Date:  2017-09-27       Impact factor: 2.537

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.